ArticleJournal of nutrition and metabolism2026
Prevalence of Xerophthalmia and Associated Factors Among Pregnant Women in Tigray Region, Ethiopia.
Article in Journal of nutrition and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Xerophthalmia and Associated Factors Among Pregnant Women in Tigray Region, Ethiopia.Journal of nutrition and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Xerophthalmia during pregnancy is a major public health problem, associated with an increased risk of morbidity and mortality among pregnant women. Studies indicated that Ethiopia is a country with the highest rates of xerophthalmia. However, most studies emphasize biochemical deficiency or night blindness rather than the full clinical spectrum. This study was intended to assess all clinical forms of xerophthalmia. Objective: The study assessed the prevalence and associated factors of xerophthalmia among pregnant women attending antenatal care in general and referral public hospitals of the Tigray Region, Ethiopia, in 2024. Methods: Using an institution-based cross-sectional design, a total of 1387 pregnant women were selected using a systematic random sampling technique to assess for xerophthalmia. The data collection was conducted from February 2024 to July 2024. Results were presented as adjusted odds ratios (AORs) with 95% CI and significance level Results: Out of the total 1387 selected pregnant women, 1355 participated, yielding a response rate of 97.83%. The prevalence of xerophthalmia was 25% (95% CI: 22.7%-27.3%). Factors significantly associated with xerophthalmia include inadequate sanitation (AOR = 2.369; 95% CI: 1.335-4.202), not taking iron supplementation (AOR = 2.577; 95% CI: 1.551-4.284), fewer antenatal care follow-ups (AOR = 3.462; 95% CI: 2.203-5.441), not owning livestock (AOR = 9.528; 95% CI: 5.666-16.023), history of miscarriage (AOR = 7.984; 95% CI: 4.361-14.614), alcohol consumption during pregnancy (AOR = 8.045; 95% CI: 3.94-16.425), consuming inadequate vegetables (AOR = 1.68; 95% CI: 1.18-2.40), and mid-upper arm circumference < 23 cm (AOR = 2.20; 95% CI: 1.58-3.08). Conclusions: Xerophthalmia among pregnant women in the Tigray Region indicates a critical public health concern. Inadequate sanitation, alcohol consumption during pregnancy, history of miscarriage, not owning livestock, low ANC attendance, inadequate vegetable consumption, undernutrition, and lack of iron supplementation during pregnancy were significantly associated with xerophthalmia. Therefore, we recommend adequate sanitation, avoiding alcohol consumption during pregnancy, preventing miscarriage, owning livestock in the household, ANC attendance, consuming vegetables, preventing acute malnutrition, and iron supplementation during pregnancy as effective interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.